RasGRP4 may thus constitute a potential therapeutic objective for the management of this state, and strict glycemic control in affected patients in clinical practice may help diminish the incidence and severity of AKI and enhance the prognosis of patients with AKI. This evidence concerns the gene RASGRP4 and acute kidney injury.